Summary 29 30
De novo genetic mutations represent a major contributor to pediatric disease, including autism 31 spectrum disorders (ASD), congenital heart disease, and muscular dystrophies 1, 2 , but there are 32 currently no methods to prevent or predict them. These mutations are classically thought to occur 33 either at low levels in progenitor cells or at the time of fertilization 1, 3 and are often assigned a 34 low risk of recurrence in siblings 4, 5 . Here, we directly assess the presence of de novo mutations 35 in paternal sperm and discover abundant, germline-restricted mosaicism. From a cohort of ASD 36 cases, employing single molecule genotyping, we found that four out of 14 fathers were germline 37 mosaic for a putatively causative mutation transmitted to the affected child. Three of these were 38 enriched or exclusively present in sperm at high allelic fractions (AF; 7-15%); and one was 39 recurrently transmitted to two additional affected children, representing clinically actionable 40 information. Germline mosaicism was further assessed by deep (>90x) whole genome 41 sequencing of four paternal sperm samples, which detected 12/355 transmitted de novo single 42 nucleotide variants that were mosaic above 2% AF, and more than two dozen additional, non-43 transmitted mosaic variants in paternal sperm. Our results demonstrate that germline mosaicism 44 is an underestimated phenomenon, which has important implications for clinical practice and in 45 understanding the basis of human disease. Genetic analysis of sperm can assess individualized 46 recurrence risk following the birth of a child with a de novo disease, as well as the risk in any 47 male planning to have children. , which have the potential to influence health of the child and impact biological 53 fitness 6 . Consequently, severe early-onset conditions, such as congenital heart disease, epilepsy, 54 or intellectual disabilities are enriched for de novo mutations that activate or inactivate critical 55 genes 7 . Although this applies broadly to autism spectrum disorders (ASD), high impact dSNVs 56 are concentrated among a subset of cases with low IQ 8 . 57
The majority of de novo mutations originate in the parental germline [9] [10] [11] . Depending on the 58 timing and location of the mutation, these may be mosaic throughout the body or only in the 59 parental germline, and they could transmit to multiple offspring. Indeed, this has been 60 documented in families with recurrent de novo mutations as well as in recent studies that 61 assessed parental mosaicism 1, 9, 10 . Two crucial questions, however, remain unaddressed: What is 62 7 Orthogonal validation by Sanger sequencing and ddPCR confirmed germline presence of most 119 variants with AF above 2% (5/6 by Sanger sequencing), but not those below this threshold (0/6 120 by ddPCR) (Fig. 2f and Extended Data Fig. 5 ). Based on this and the baseline risk of ASD in the 121 general population of ~1.5%, we used 2% as the threshold for clinically relevant mosaicism. Of 122 all dSNVs, 3.38% (all) and 5.92% (pat) exceeded this level (Fig. 2c) . These data suggest that, in 123 the absence of selection acting on the pathogenic mutation, more than 3% of diseases caused by 124 dSNVs have a risk of recurrence that is substantially elevated when compared to the basal 125 population-wide risk 16 . Moreover, for the majority of cases this risk cannot be assessed 126 accurately in somatic tissues, but can be assessed in paternal sperm. 127
We also studied the genome-wide extent of mosaic variation in sperm using the WGS data (Fig.  128   3a) . We identified high-quality sperm-specific mosaic variants using a stringent pipeline that 129 utilized two mosaic detection algorithms: MuTect and Strelka. We further excluded likely false 130 calls in repetitive regions or within ±5 base pairs of a germline insertion or deletion variant. In 131 total, we detected 30 mosaic SNVs with AF between 29.8% and 3.7% in the sequenced sperm 132 from the four fathers ( Fig. 3b- Fig. 6e-f) . 135
We likely underestimated the true number of mosaic SNVs, as we could only detect mosaic 136 variants above 4% AF at current sequencing depth of >90x. Moreover, we only detected the top-137 ranked variant (Chr22:23082101A>G in F08) from the pool of 39 mosaic dSNVs ( Fig. 2f and  138 Supplementary Table 4) . Future efforts to detect lower frequency, pathogenic variants in sperm 139 will require improved algorithms for detection, higher sequencing depths, or both. A cost-140 effective way to achieve this would be to sequence targeted regions of interest (e.g. the exome, 141 8 haploinsufficient genes, or candidate genes for sporadic diseases). Nevertheless, the relatively 142 high frequency of germline mosaicism with variants present at high AF argues for the clinical 143 utility of screening sperm to identify carriers prior to conception. Furthermore, a complementary 144 analysis of blood-specific mosaicism suggested a largely distinct set of variants from those 145 evident in the germ cells (Extended Data Fig. 7 ). This should be explored further by increasing 146 the sensitivity of mosaic detection, which would allow for the detailed interrogation of lineage 147 and mutational rate differences between these tissues 17, 18 . 148
Finally, to determine if this approach could be applied to other forms of genetic variation, we 149 tested germline mosaicism of two structural de novo variant classes: 1) large deletions and 150 duplications, and 2) short tandem repeat (STR) expansions and contractions. F21 and F22 both 151 harbor likely pathogenic de novo structural variants: a ~1.5 Mb duplication (F21) and a 130 kb 152 deletion (F22) (Fig. 4a) 
12
. While the duplication in F21 and a non-pathogenic, additional deletion 153 in F22 did not appear to be mosaic in sperm (Extended Data Fig. 8d-g ), we found evidence of 154 sperm-specific mosaicism for the pathogenic deletion in F22 using read depth and split-read 155 information (Extended Data Fig. 8a,b) . This was confirmed with a PCR based strategy, and copy 156 number detection by ddPCR estimated 0.15 deletion copies in paternal sperm, or an effective AF 157 of ~7.5% given the presence of an unaffected reference allele in the genome (Fig. 4b-d and  158 Extended Data Fig. 8c) . 159
Short tandem repeats (STRs) are particularly dynamic in the genome and can expand or contract 160 de novo during transcription, replication, and meiosis, impacting gene functions and causing 161 diseases such as Huntington's disease or Fragile X syndrome 19, 20 . As de novo short tandem 162 repeat changes (dSTRΔs) have to date not been implicated in ASD, we could not identify likely 163 pathogenic variants. Therefore, we adopted a strategy similar to the one used to evaluate dSNVs:9 calling non-pathogenic dSTRΔs using WGS data and then evaluating their presence in paternal 165 sperm and blood ( Fig. 2a and 4e) . We detected 86 non-pathogenic dSTRΔs, five of which were 166 exclusively mosaic in the paternal sperm at an AF ranging from 17.5% to 1.9% (Fig. 4e,  167 Extended Data Fig. 9a -e, and Supplementary Table 5 ). The dSTRΔ with the highest AF was a 168 tetranucleotide repeat expansion in the child (Fig. 4f) . It was not present in the somatic tissues of 169 either parent, but was detected in the father's germline with a 17.5% AF (Fig. 4g and Extended 170
Data Fig. 9f-g ). Highly unstable STR pre-mutations may be prone to early mosaicism. Assessing 171 dSTRΔs in the germline in pre-mutation carriers may help to adjust the individualized risk to 172
offspring. 173
This study is the first, to our knowledge, to directly assess this type of mosaicism in a relevant 174 germline tissue, paternal sperm. While previous reports have estimated germline mosaicism from 175 dSNV recurrence among siblings or detection in peripheral tissues 9,10,21,22
, here we directly 176 measure germline mosaicism in males and present a conceptual framework for refining disease 177 risk to offspring. We show that more than 3% of dSNVs are mosaic in the paternal germline. 178
Although we focus on families with ASD, these findings are applicable to a range of diseases 179 caused by de novo mutations. The analysis of sperm instead of non-germline tissues could be an 180 important addition to clinical practice allowing for accurate prediction of recurrence risk, but 181 also for detection of previously non-transmitted, mosaic mutations prior to conception. were kept at 100 bp or shorter and probes at 20 bp or shorter. Specificity of the primers was 234 assessed using Primer-BLAST 34 . Custom primer and probe mixes (primer to probe ratio of 3.6) 235
were ordered from IDT with FAM-labeled probes for the alternate, and HEX-labeled probes for 236 the reference allele (Supplementary Table 6 ). Optimal annealing temperature, specificity, and 237 efficiency were tested using custom gblocks (IDT) or patient DNA at a range of dilutions. 238 ddPCR was performed on a BioRad platform, using a QX200 droplet generator, a C1000 touch 239 cycler, a PX1 PCR Plate Sealer, and a QX200 droplet reader with the following reagents: ddPCR 240 were designed for SNV detection, we determined that the minimum AF that we could reliably 247 detect was 0.1%. Therefore, we set this as threshold of detection. Raw data for ddPCR 248 experiments can be found in Supplementary Table 7 . 249 250 13 Data processing. Graphs were generated and data analyzed using GraphPad Prism, R, and 251 Oxford Nanopore sequencing and analysis. We generated whole genome sequencing libraries 267
Python (matplotlib library
with Oxford Nanopore 1D long reads for four affected probands (Families: F08, F09, F21, and 268 F22) according to manufacturer's recommendations. FASTQs were aligned to the hg19 reference 269 genome with bwa mem with the '-x ont2d' option for ONP reads. Coverage of proband samples 270 ranged from 15x to 3x (average 9x) with average read length ranging from 7,839bp to 4,645bp 271 (average: 6,777bp). 272
273
Haplotype phasing. To determine dSNV phase, we first identified a set of phase-informative 274 SNPs using the germline variant calls from our 40x WGS data. Phase-informative SNPs were 275 those where the child was heterozygous and either 1) one parent was heterozygous or 276 homozygous for the alternate allele while the other parent was homozygous for the reference 277 allele, or 2) one parent was heterozygous while the other parent was homozygous for the 278 alternate allele. Second, we identified long-reads (Oxford Nanopore reads, average length 6,777 279 bp) that contained both a dSNV and one or more phase-informative SNPs. We then counted the 280 number of dSNV and phase-informative SNP combinations that were present in reads and 281 consistent with the dSNV occurring on a maternal or paternal haplotype. Reads containing an 282 INDEL flanking either the dSNV or the phase-informative SNP were excluded from the analysis. 283
Finally, we assigned the dSNVs to maternal and paternal haplotypes if there were: 1) a minimum 284 of two counts, and 2) the haplotype with the majority of counts had at least 2/3 of total counts. 285
Out of the 256 variants from the four affected children, we succeeded in phasing for 187 286 (73.0%), of which 152 were phased to the paternal haplotype (81.3%; α~4). These paternal 287 dSNVs were then used for further analysis as described below. 288 289 Mosaic dSNV analysis. Using the read information generated by HaplotypeCaller, we 290 determined AF for previously called dSNVs. We additionally annotated dSNVs that fell in 291 repetitive regions of the human genome using the repeatMasker (rmsk.txt) file from UCSC. We 292 manually filtered those variants that were homozygous in the reference and heterozygous in the 293 proband, as well as variants that were present in both blood and sperm at AF that suggested an 294 inherited heterozygous SNP (i.e. AF>35% in both blood and sperm). This resulted in a total of 295 355 dSNVs that were analyzed, 152 being paternally phased (see phasing methods). Out of 355 296 variants, 169 were outside of repetitive regions. Separate analysis of these, revealed similar rates 297 of mosaicism (Supplementary Table 3 ). Thus, we concluded that assessment of all variants is 298 acceptable for this approach. Out of the total of 355, 59 (all) and 12 (AF>2%) were showing read 299 evidence in sperm, blood, or both. 7 (all) and 2 (AF>2%) of these were phased to the maternal 300 haplotype (i.e. were most likely false positives). Out of the paternally phased 152 variants, 29 301 (all) and 9 (AF>2%) were showing read evidence in sperm, blood, or both. Mosaic variants were 302 categorized based on their presence or absence in sperm and blood. To be called sperm enriched, 303 a variant's AF had to be three times higher in sperm than in blood (α>3). MarkDuplicates (v1.128, http://broadinstitute.github.io/picard) and INDELs were realigned 309 using GATK's IndelRealigner (v3.5) 24 . We then called sperm-and blood-specific SNVs using 310 two somatic variant callers with default parameters, Strelka (v2.7.0) 36 and muTect (v3.1) 37 , 311 setting the sperm sample as "tumor" and the blood sample as "normal". For blood specific-312 variants, we did the reverse. We defined a high threshold for somatic calls for each sperm-blood 313 and blood-sperm comparison by taking the intersection of variants identified by both Strelka and 314
MuTect. These high quality calls were further filtered to reduce potential false positives as 315 follows. We removed calls that fell into repetitive regions, using the RepeatMasker (rmsk.txt) 316 file from UCSC, and removed calls that fell within 5 bp of a germline INDEL. For mosaic 317 variant analysis in blood, F09 was an outlier with respect to number of variants that were called. 318
Consequently, analyses were performed with and without variants from this individual to reflect 319 this issue. 320
321
Mosaic SV analysis of WGS data. We searched for evidence for mosaicism in the fathers using 322 depth of coverage, split-reads, discordant paired-ends, and B-allele frequency in deeply 323 sequenced paired-end genomes. Depth of coverage was estimated as the median per base-pair 324 coverage within the SV locus, while omitting positions that overlapped assembly gaps, 325
RepeatMasker elements, short tandem repeats, and segmental duplications. We estimated copy 326 number by dividing the median depth of coverage by the median coverage of the chromosome 327 and multiplying by 2. Split-reads (also known as chimeric reads) are those with multiple 328 alignments to the genome. If a read spanned a deletion or tandem duplication breakpoint, two 329 alignments were generated with each segment mapping to opposite ends of the breakpoint. 330
Similar to split-reads, discordant paired-ends had read fragments that span the SV breakpoint, 331 but the SV breakpoint resided in the unsequenced insert of the fragment. Consequently, the 332 paired-ends mapped to opposite ends of the breakpoint producing an insert size approaching the 333 size of the SV. We searched ±250 bp from the predicted breakpoint for SV supporting reads, 334 which were unique reads that were either split or contained discordant paired-ends with 335 breakpoints that overlap at least 95% reciprocally to the SV. We reported the proportion of 336 supporting reads to non-informative reads (those that do not support the SV) within the +/-250bp 337 windows, which roughly estimates proportion of mosaicism. Additionally for the de novo 338 duplication SV, we searched for deviations in B-allele frequency defined as the proportion of 339 reads that support the alternate variant to all reads covering the variant in question. 340
341
Mosaic SV analysis using PCR and ddPCR. Nested PCR was performed using blood DNA 342 extracted from the F22 trio (proband, mother, and father), as well as sperm from the F22 father 343 and a non-related male. Primers were designed using Primer3Plus online software 31 to span the 344 deletion breakpoints within CACNG2 determined by WGS analysis within 500 bp windows up-345 and down-stream of the predicted deletion. Additionally, a reverse primer was designed to be 346 used with the nested forward primer as an amplification control (Supplementary Table 6 ). All 347 PCR reactions were 25 µl volumes and included 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 2 mM 348
MgCl2, 1 U of Taq (Thermo Fisher Scientific, Waltham, MA), and 300 nM of each appropriate 349 primer. DNA template was 50 ng of DNA from blood or sperm for the initial PCR (using the 350 external set of primers), or 1 µl of the initial PCR product for the nested (internal) PCR. PCR 351 reactions were run following a standard ramp speed protocol using a C1000 Touch Table 6 ). Probe annealing temperature was designed to be 5°C higher than the primer binding 357 temperatures. Primers were designed to span the deletion breakpoints within CACNG2. A custom 358 primer and FAM-labeled probe mix at a primer:probe ratio of 750 nM:250 nM was ordered from 359 Bio Rad (Hercules, CA) as well as a HEX-labeled pre-validated copy number variation assay 360 specific for RPP30 as an internal control (assay ID: dHsaCP2500350). ddPCR was performed 361 and analyzed as described above. Raw data for ddPCR experiments can be found in 362
Supplementary (version v0.2-311-g9bcd580) jointly on all BAM files (40x trios and >90x 366 blood and sperm of fathers). We used the reference STR set provided by HipSTR for GRCh37 367 (GRCh37.hipstr_reference.bed) and default options except for: --def-stutter-model and --output-368 gls. We further ran HipSTR's denovofinder tool on each of the 40x trios with the option --369 uniform-prior. The following, strict filters were applied for the detection of a de novo: required 370 genotype call in all family members; posterior probability of de novo mutation ≥0.9; ignored 371 mutations that are not a multiple of the repeat unit; ignored if allele lengths followed Mendelian 372 inheritance or if de novo allele also was found in one of the parents; minimum genotype quality 373 of 0.9 in all family members; minimum percentage of reads with stutter or INDEL was 20% for 374 all family members; required at least 10 spanning reads in all family members; required at least 375 20% of reads to support each allele in each family member; new allele was excluded if 376 homozygous in the child; removed segmental duplications (UCSC segmental duplication 377 track) 39, 40 ; and removed calls that overlapped with >10 entries in DGV 41 . We then annotated the 378 remaining loci with their frequencies in the >90x sperm and blood samples. We calculated the 379 posterior probability of a de novo mutation using HipSTR outputs of no mutation, de novo 380 mutation, and other. We converted this to a posterior assuming the following priors: 381 prob(mutation)=0.0001 and prob(other)=0.01. dSTRΔs were qualified as inconclusive if 382 mosaicism was detected in mother and father or only in paternal blood; as true de novo if no 383 mosaicism was detected in the parents; as maternal if mosaicism was only detected in the 384 mother; and as paternal if mosaicism was detected in blood and sperm, or sperm only. Table 2 ). Note that only II-3 met the criteria for bona fide ASD and was the only child included 517 in the original trio-based study. d, Schematic of GRIN2A and the mutation that was found in all 518 three children and affected a splice site. 
